David L Grange's Net Worth
$1.09 Million
Who is David L Grange?
David L Grange has an estimated net worth of $1.09 Million. This is based on reported shares across multiple companies, which include Tonix Pharmaceuticals Holding Corp., and PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
SEC CIK
David L Grange's CIK is 0001264908
Past Insider Trading and Trends
2005 was David L Grange's most active year for acquiring shares with 4 total transactions. David L Grange's most active month to acquire stocks was the month of April. 2007 was David L Grange's most active year for disposing of shares, totalling 11 transactions. David L Grange's most active month to dispose stocks was the month of October. 2010 saw David L Grange paying a total of $1,137,530.94 for 201,753 shares, this is the most they've acquired in one year. In 2010 David L Grange cashed out on 103,506 shares for a total of $1,330,677.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tonix Pharmaceuticals Holding Corp. (TNXP) Snapshot price: $0.16
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
| No matching records found | |||||||||
PHARMACEUTICAL PRODUCT DEVELOPMENT INC No price found
Chief Executive OfficerDavid L Grange owns 61,045 units of Common Stock. From 2003 to 2011 David L Grange acquired a total of 184,244 shares in PHARMACEUTICAL PRODUCT DEVELOPMENT INC at a cost of $2,767,708.27, David also disposed a total of 125,811 shares of PHARMACEUTICAL PRODUCT DEVELOPMENT INC equalling to $3,853,596.39.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$23.23 | -$191,480.55 | 61.05K |
Feb 28
| |||
Form 4
|
—
|
0
|
$23.85 | -$193,146.86 | 61.05K |
Nov 2 - Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| +452.69% | 50K |
—
|
—
| 61.05K |
Jul 1
| |||
Form 4
| +25.47% | 2.24K |
—
|
—
| 11.04K |
Jan 2
| |||
Form 4
|
—
|
0
|
$37.89 | -$69,847.59 | 8.8K |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| +22.01% | 1.59K |
—
|
—
| 8.8K |
Jan 2
| |||
Form 4
|
—
|
0
|
$28.78 | -$54,454.26 | 7.21K |
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
$24.60 | -$114,470.86 | 7.21K |
Feb 9
| |||
Form 4
| +38.11% | 1.99K |
—
|
—
| 7.21K |
Jan 3
| |||
Form 4
|
—
|
0
|
$25.65 | -$211,800.00 | 5.22K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +65.32% | 1.03K |
—
|
—
| 2.61K |
Jan 3
| |||
Form 4
|
—
|
0
|
$41.33 | -$155,630.00 | 1.58K |
Nov 2
| |||
Form 4
|
—
|
0
|
$41.61 | -$95,058.00 | 1.58K |
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
∞
| 1.58K |
—
|
—
| 1.58K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||